FAKTOR-OPTIONSSCHEIN - AMGEN | Market Closed - Boerse Frankfurt Warrants 03:41:51 2024-06-07 pm EDT | ||
| 12.7 EUR | -0.16% |
|
| Current month | +0.87% | ||
| 1 month | +2.74% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-07 | 12.76 | +0.31% |
| 24-06-06 | 12.72 | -1.09% |
| 24-06-05 | 12.86 | 0.00% |
| 24-06-04 | 12.86 | +0.94% |
| 24-06-03 | 12.74 | +0.71% |
Real-time Boerse Frankfurt Warrants
Last update June 07, 2024 at 03:41 pm EDT
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SB01EX |
| ISIN | DE000SB01EX7 |
| Date issued | 2020-06-09 |
| Strike | 225.4 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.85 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 15.1 € |
|---|---|
| Lowest since issue | 6.3 € |
| Spread | 0.03 € |
| Spread % | 0.24% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305
USD
Average target price
316.3
USD
Spread / Average Target
+3.69%
- Stock Market
- Certificates
- Certificat
